A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

BACKGROUND: Pomaglumetad methionil (LY2140023 monohydrate) is a potent and highly selective agonist for the metabotropic glutamate mGluR2 and mGluR3 receptors. We present results of a pivotal clinical study H8Y-MC-HBBM assessing the efficacy of LY2140023 in improving symptoms as a monotherapy in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Downing, AnnCatherine M, Kinon, Bruce J, Millen, Brian A, Zhang, Lu, Liu, Lin, Morozova, Margarita A, Brenner, Ronald, Rayle, Tami Jo, Nisenbaum, Laura, Zhao, Fangyi, Gomez, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276262/
https://www.ncbi.nlm.nih.gov/pubmed/25539791
http://dx.doi.org/10.1186/s12888-014-0351-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276262/
https://www.ncbi.nlm.nih.gov/pubmed/25539791
http://dx.doi.org/10.1186/s12888-014-0351-3

Ejemplares similares